Pathophysiology and therapy of irinotecan (CPT-11) induced delayed onset diarrhea (DD): A prospective assessment

被引：0
|
作者：
Misset, JL
Saliba, F
Giacchetti, S
Brain, E
Vassal, G
Bonnay, M
Bastian, G
Cote, C
Mahjoubi, M
Herait, P
Hagipantelli, R
Cvitkovic, E
机构：
[1] HOP PAUL BROUSSE,VILLEJUIF,FRANCE
[2] IGR,VILLEJUIF,FRANCE
[3] SOMPS,PARIS,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：742 / 742
页数：1
相关论文
共 50 条
  • [41] Investigation of the Possible Protective Effect of N-Acetylcysteine (NAC) against Irinotecan (CPT-11)-Induced Toxicity in Rats
    Gencosman, Sevgi
    Ceylanli, Deniz
    Sehirli, Ahmet Ozer
    Terali, Kerem
    Bolukbasi, Furkan
    Cetinel, Sule
    Sayiner, Serkan
    ANTIOXIDANTS, 2022, 11 (11)
  • [42] A phase I/II study of 24-hour infusional irinotecan (CPT-11) therapy in metastaic colorectal cancer.
    Tsui, A
    Kobayashi, K
    Shima, Y
    Hamada, M
    Nishioka, Y
    Morita, S
    Horimi, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 289S - 289S
  • [43] RETROSPECTIVE SINGLE INSTITUTION EXPERIENCE OF CISPLATIN AND IRINOTECAN (CPT-11) AS FIRST-LINE THERAPY IN ADVANCED GASTRIC OR GASTROESOPHAGEAL ADENOCARCINOMA
    Machado, K. K.
    Stelko, G. L. P.
    Oliveira, S. C. R.
    Freitas, H. C.
    Hoff, P. M.
    ANNALS OF ONCOLOGY, 2010, 21 : 119 - 119
  • [44] Combination therapy with irinotecan (CPT-11), mitoxantrone, and dexamethasone in relapsed or refractory non-Hodgkin's lymphoma: a pilot study
    Niitsu, N
    Iijima, K
    Chizuka, A
    ANNALS OF HEMATOLOGY, 2001, 80 (07) : 411 - 416
  • [45] Combination therapy with irinotecan (CPT-11), mitoxantrone, and dexamethasone in relapsed or refractory non-Hodgkin's lymphoma: a pilot study
    N. Niitsu
    K. Iijima
    A. Chizuka
    Annals of Hematology, 2001, 80 : 411 - 416
  • [46] Synthesis of novel benzils and benzoins as selective inhibitors of mammalian carboxylesterases designed to ameliorate the delayed diarrhea associated with CPT-11 treatment.
    Hicks, Latorya D.
    Hyatt, Janice L.
    Wadkins, Randy M.
    Edwards, Carol C.
    Tsurkan, Lyudmila
    Weirdl, Monika
    Potter, Philip M.
    CANCER RESEARCH, 2006, 66 (08)
  • [47] Involvement of UDP-glucuronosyltransferase activity in irinotecan-induced delayed-onset diarrhea in rats
    Masaharu Onoue
    Akinobu Kurita
    Shoichi Kado
    Tsuneo Matsumoto
    Norimasa Kaneda
    Kazumi Uchida
    Ikuo Kato
    Teruo Yokokura
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 595 - 605
  • [48] Involvement of UDP-glucuronosyltransferase activity in irinotecan-induced delayed-onset diarrhea in rats
    Onoue, Masaharu
    Kurita, Akinobu
    Kado, Shoichi
    Matsumoto, Tsuneo
    Kaneda, Norimasa
    Uchida, Kazumi
    Kato, Ikuo
    Yokokura, Teruo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (04) : 595 - 605
  • [49] A Phase II study of CPT 11 (Irinotecan) in refractory to 5 FU colorectal cancer (CRC) with, preventive treatment of delayed diarrhea by Acetorphan
    Extra, JM
    Rougier, P
    Ychou, M
    Douillard, JY
    Adenis, A
    Mousseau, M
    Assadourian, S
    Mahjoubi, M
    Marty, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 727 - 727
  • [50] A phase II study of CPT 11 (irinotecan) in refractory to 5FU colorectal cancer with curative treatment of delayed diarrhea by Acetorphan
    Merrouche, Y
    Bugat, R
    Brunet, R
    Seitz, JF
    Conroy, T
    Fabre, V
    Namer, M
    Piolat, V
    Mahjoubi, M
    Droz, JP
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 759 - 759
12345